Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

A novel proangiogenic B cell subset is increased in cancer and chronic inflammation

  • Willem van de Veen
  • , Anna Globinska
  • , Kirstin Jansen
  • , Alex Straumann
  • , Terufumi Kubo
  • , Daniëlle Verschoor
  • , Oliver F Wirz
  • , Francesc Castro-Giner
  • , Ge Tan
  • , Beate Rückert
  • , Urs Ochsner
  • , Marietta Herrmann
  • , Barbara Stanić
  • , Marloes van Splunter
  • , Daan Huntjens
  • , Alexandra Wallimann
  • , Rodney J Fonseca Guevara
  • , Hergen Spits
  • , Desislava Ignatova
  • , Yun-Tsan Chang
  • Christina Fassnacht, Emmanuella Guenova, Lukas Flatz, Cezmi A Akdis, Mübeccel Akdis

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Abstract

B cells contribute to immune responses through the production of immunoglobulins, antigen presentation, and cytokine production. Several B cell subsets with distinct functions and polarized cytokine profiles have been reported. In this study, we used transcriptomics analysis of immortalized B cell clones to identify an IgG4+ B cell subset with a unique function. These B cells are characterized by simultaneous expression of proangiogenic cytokines including VEGF, CYR61, ADM, FGF2, PDGFA, and MDK. Consequently, supernatants from these clones efficiently promote endothelial cell tube formation. We identified CD49b and CD73 as surface markers identifying proangiogenic B cells. Circulating CD49b+CD73+ B cells showed significantly increased frequency in patients with melanoma and eosinophilic esophagitis (EoE), two diseases associated with angiogenesis. In addition, tissue-infiltrating IgG4+CD49b+CD73+ B cells expressing proangiogenic cytokines were detected in patients with EoE and melanoma. Our results demonstrate a previously unidentified proangiogenic B cell subset characterized by expression of CD49b, CD73, and proangiogenic cytokines.

OriginalspracheEnglisch
Aufsatznummereaaz3559
FachzeitschriftScience Advances
Volume6
Ausgabenummer20
DOIs
PublikationsstatusVeröffentlicht - Mai 2020
Extern publiziertJa

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gute Gesundheit und Wohlergehen
    SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

  • 302 Klinische Medizin

Dieses zitieren